Stock comparison
Alphatec Holdings
United Therapeutics
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
ATEC
Alphatec Holdings
Market cap
$1.27B
Sector
Healthcare
UTHR
United Therapeutics
Market cap
$24.13B
Sector
Healthcare
Overall winner
United Therapeutics UTHR
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | ATEC | UTHR | Winner |
|---|---|---|---|
| Warren Buffett | 26F | 71B | UTHR |
| Benjamin Graham | 65D | 76B | UTHR |
| Philip Fisher | 50C | 76B | UTHR |
| Peter Lynch | 71C | 62C | ATEC |
| Joel Greenblatt | 0F | 46D | UTHR |
| Charlie Munger | 37D | 64C | UTHR |
| Terry Smith | 33F | 64C | UTHR |
Side-by-side metrics
| Metric | ATEC | UTHR |
|---|---|---|
| Market cap | $1.27B | $24.13B |
| P/E (TTM) | - | 19.2x |
| EV/EBIT | - | 15.2x |
| ROIC (TTM) | -8.94% | 18.81% |
| Gross margin | 65.32% | 86.58% |
| Net margin | -15.93% | 40.61% |
| Revenue CAGR 5y | 33.14% | 17.22% |
| EPS CAGR 5y | - | 29.84% |
| Debt / Equity | 33.0x | - |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
ATEC leads on
- EV/EBIT-vs 15.2x+175%
- P/E (TTM)-vs 19.2x+150%
- Revenue CAGR 5y33.14%vs 17.22%+48%
UTHR leads on
- ROIC (TTM)18.81%vs -8.94%+148%
- Net margin40.61%vs -15.93%+139%
- Debt / Equity-vs 33.0x+100%
- Market cap$24.13Bvs $1.27B+95%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.